Generation of drug-resistant mutants of Helicobacter pylori in the presence of peroxynitrite, a derivative of nitric oxide, at pathophysiological concentration - PubMed (original) (raw)
Generation of drug-resistant mutants of Helicobacter pylori in the presence of peroxynitrite, a derivative of nitric oxide, at pathophysiological concentration
Hideo Kuwahara et al. Microbiol Immunol. 2009 Jan.
Free article
Abstract
In the present study it has been shown that the reactive nitrogen species, peroxynitrite, can cause at least a 7.1-fold increase in the frequency of occurrence of drug-resistant mutants of Helicobacter pylori at a pathophysiological concentration (e.g. 1.0 microM) and in the presence of CLR. Furthermore, the CLR MIC of these resistant H. pylori strains increased by at least 250 times or higher in CLR susceptibility. In the 45 resistant strains, the modification of 23S rRNA A2142G was the predominant mutation (22/45), followed by A2143G (17/45) within the sequences of 23S rRNA. The other mutants were one each (1/45) in A2142T, and T2269G, and two each (2/45) in C2695G and T1944C, respectively. These results show that the inflammatory host reaction involving induction of reactive oxygen species (e.g. O(.-)2), and the inducible form of nitric oxide synthase, is a significant cause of mutation via peroxynitrite formation, particularly in drug-resistant bacterial strains.
Similar articles
- Modified allele-specific primer-polymerase chain reaction method for analysis of susceptibility of Helicobacter pylori strains to clarithromycin.
Furuta T, Soya Y, Sugimoto M, Shirai N, Nakamura A, Kodaira C, Nishino M, Okuda M, Okimoto T, Murakami K, Fujioka T, Hishida A. Furuta T, et al. J Gastroenterol Hepatol. 2007 Nov;22(11):1810-5. doi: 10.1111/j.1440-1746.2007.04919.x. J Gastroenterol Hepatol. 2007. PMID: 17914955 - Contribution of efflux pumps to clarithromycin resistance in Helicobacter pylori.
Hirata K, Suzuki H, Nishizawa T, Tsugawa H, Muraoka H, Saito Y, Matsuzaki J, Hibi T. Hirata K, et al. J Gastroenterol Hepatol. 2010 May;25 Suppl 1:S75-9. doi: 10.1111/j.1440-1746.2009.06220.x. J Gastroenterol Hepatol. 2010. PMID: 20586871 - Mutations in the 23S rRNA gene of clarithromycin-resistant Helicobacter pylori from Japan.
Rimbara E, Noguchi N, Kijima H, Yamaguchi T, Kawai T, Sasatsu M. Rimbara E, et al. Int J Antimicrob Agents. 2007 Sep;30(3):250-4. doi: 10.1016/j.ijantimicag.2007.04.009. Epub 2007 Jun 21. Int J Antimicrob Agents. 2007. PMID: 17590317 - [Clinical significance of H. pylori genotyping].
Mirodzhov GK, Mansurova FKh, Ishankulova DM. Mirodzhov GK, et al. Klin Med (Mosk). 2008;86(12):8-12. Klin Med (Mosk). 2008. PMID: 19227301 Review. Russian. - Novel Helicobacter pylori therapeutic targets: the unusual suspects.
Duckworth MJ, Okoli AS, Mendz GL. Duckworth MJ, et al. Expert Rev Anti Infect Ther. 2009 Sep;7(7):835-67. doi: 10.1586/eri.09.61. Expert Rev Anti Infect Ther. 2009. PMID: 19735225 Review.
Cited by
- Analyses of repeated failures in cancer therapy for solid tumors: poor tumor-selective drug delivery, low therapeutic efficacy and unsustainable costs.
Maeda H, Khatami M. Maeda H, et al. Clin Transl Med. 2018 Mar 1;7(1):11. doi: 10.1186/s40169-018-0185-6. Clin Transl Med. 2018. PMID: 29541939 Free PMC article. - Sinapic Acid and Its Derivatives as Medicine in Oxidative Stress-Induced Diseases and Aging.
Chen C. Chen C. Oxid Med Cell Longev. 2016;2016:3571614. doi: 10.1155/2016/3571614. Epub 2015 Nov 10. Oxid Med Cell Longev. 2016. PMID: 27069529 Free PMC article. Review. - Canolol inhibits gastric tumors initiation and progression through COX-2/PGE2 pathway in K19-C2mE transgenic mice.
Cao D, Jiang J, Tsukamoto T, Liu R, Ma L, Jia Z, Kong F, Oshima M, Cao X. Cao D, et al. PLoS One. 2015 Mar 17;10(3):e0120938. doi: 10.1371/journal.pone.0120938. eCollection 2015. PLoS One. 2015. PMID: 25781635 Free PMC article. - The link between infection and cancer: tumor vasculature, free radicals, and drug delivery to tumors via the EPR effect.
Maeda H. Maeda H. Cancer Sci. 2013 Jul;104(7):779-89. doi: 10.1111/cas.12152. Epub 2013 Apr 22. Cancer Sci. 2013. PMID: 23495730 Free PMC article. Review. - Vascular permeability in cancer and infection as related to macromolecular drug delivery, with emphasis on the EPR effect for tumor-selective drug targeting.
Maeda H. Maeda H. Proc Jpn Acad Ser B Phys Biol Sci. 2012;88(3):53-71. doi: 10.2183/pjab.88.53. Proc Jpn Acad Ser B Phys Biol Sci. 2012. PMID: 22450535 Free PMC article. Review.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical